News Feature Channel: Men's Health

MRI-Guided Radiation Therapy Reduces Long-Term Side Effects for Patients with Prostate Cancer

University of California, Los Angeles (UCLA), Health Sciences — Wed, 13 Nov 2024 12:35:54 EST

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality of life, particularly in bowel and sexual health, compared to conventional CT-guided treatment.

Estudio: Los Adultos Mayores con Cancer de Prostata Reciben Mas Tratamientos Excesivos

Cedars-Sinai — Mon, 11 Nov 2024 13:00:58 EST

Segun un nuevo estudio dirigido por Cedars-Sinai, un porcentaje de hombres estadounidenses de edad avanzada con cancer de prostata de riesgo intermedio y alto se someten a tratamientos que conllevan riesgos de efectos secundarios que pueden reducir significativamente la calidad de vida sin prolongarla.

Social Media Likes and Comments Linked to Young Men's Obsession with Perfect Pecs and a Six-Pack

University of South Australia — Wed, 06 Nov 2024 16:00:06 EST

Social media platforms like TikTok and Instagram are fuelling unrealistic, unhealthy obsessions with a lean and muscular physique among many young men, according to a new Australian study.

Researchers Report First Published Case of a Patient with Treatment-Emergent Neuroendocrine Prostate Cancer Who Showed a Remarkable Response to an Anti-HER2 Antibody-Drug Conjugate

American College of Physicians (ACP) — Mon, 04 Nov 2024 17:00:00 EST

A new case report published in Annals of Internal Medicine describes the success of human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate trastuzumab deruxtecan (T-DXd) in a patient with HER2-expressing treatment-emergent neuroendocrine prostate cancer (t-NEPC).

First of a Kind Case Study Shows Remarkable Improvements for Prostate Cancer Patient

George Washington University — Mon, 04 Nov 2024 12:00:40 EST

Researchers from the George Washington University and the Washington DC Veterans Affairs Medical Center have published a landmark case report that signifies a potential breakthrough in the treatment... ...

Actor James Van Der Beek Announces Colon Cancer Diagnosis At Age 47, Part Of A Growing Trend of Young Colorectal Cancers Diagnoses

Hackensack Meridian Health — Mon, 04 Nov 2024 10:10:52 EST

John Theurer Cancer Center First in the Country to Evaluate New AI Technology Assessing Aggressiveness of Prostate Cancer Post Surgery

Hackensack Meridian Health — Wed, 30 Oct 2024 10:35:30 EST

Nitin Yerram, MD, co-director of urologic oncology at JTCC, received a grant from Artera to assess the MMAI platform for estimating prostate cancer aggressiveness in men who have had a prostate biopsy and underwent surgery.

'The Way to a Man's Heart Disease': Can Social Expectations of Masculinity Be Bad for Cardiovascular Health?

University of Chicago Medical Center — Fri, 25 Oct 2024 11:00:00 EST

A new study found that higher levels of stereotypical male gender expression were associated with a decrease in reported diagnoses and treatment for cardiovascular disease risk factors.

Sylvester Cancer Tip Sheet - Oct. 2024

Sylvester Comprehensive Cancer Center — Thu, 24 Oct 2024 13:10:13 EST

Transforming breast cancer treatment and prevention, a breast-cancer survivor and doctoral candidate focuses her research on adolescent and young adult cancer disparities, research on tracking glioblastoma progression and more are included in this month's tip sheet.

New Advances in Prostate Cancer Diagnosis: Outcomes from the 2022 Panjiayuan Consensus Conference

Chinese Academy of Sciences — Thu, 24 Oct 2024 09:55:31 EST

The 2022 Panjiayuan Consensus Conference, held by the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, has introduced pivotal advancements in prostate targeted biopsy (TB) strategies and development, marking a significant leap forward in the diagnosis and management of prostate cancer (PCa).

UCLA Efforts to Provide Prostate Cancer Treatment in the Community Gets $6 Million Boost

University of California, Los Angeles (UCLA), Health Sciences — Tue, 22 Oct 2024 10:35:01 EST

The UCLA Urology department has been awarded $6 million from the California Department of Health Care Services to continue providing vital care and critical services to underinsured and uninsured Californians diagnosed with prostate cancer.

Sarasota Memorial Research Institute Participates in Groundbreaking Prostate Cancer Imaging Study

Sarasota Memorial Hospital — Mon, 21 Oct 2024 13:50:28 EST

Prostate cancer is the most common non-skin cancer in men in the US, and the 4th most common tumor diagnosed worldwide. As part of its commitment to improving the diagnosis and staging of this disease, Sarasota Memorial Research Institute is proud to announce its participation in the Solar-Stage study sponsored by Curium.

Dr. Luca Valle Receives VA Grant to Improve Prediction of Radiorecurrent Prostate Cancer Outcomes

University of California, Los Angeles (UCLA), Health Sciences — Mon, 21 Oct 2024 10:50:46 EST

UCLA's Dr. Luca Valle was awarded a $2.1 million grant from the U.S. Department of Veterans Affairs to develop new methods to better understand the clinical scope and biological factors that lead to prostate cancer coming back after radiation therapy.

Moffitt Study Reveals Insights Into Oral HPV Incidence and Risks in Men Across 3 Countries

Moffitt Cancer Center — Mon, 21 Oct 2024 09:05:54 EST

A new study has unveiled crucial information about the incidence and risk factors of oral human papillomavirus (HPV) infections among men in the United States, Mexico and Brazil. Moffitt Cancer Center researchers have discovered how often new oral HPV infections occur, the factors influencing their acquisition and the regional variations in infection rates.

Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer from Progressing to More Dangerous States During Active Surveillance

Johns Hopkins Medicine — Thu, 17 Oct 2024 13:00:12 EST

In a peer-reviewed study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance -- a clinical option in which men with lower risk cancer are carefully monitored for progression in lieu of treatments that could have undesired side effects or complications.

Spermatogenesis May Be Reflected Through Male Rat Urinary Proteome Changes After Mating

Chinese Academy of Sciences — Fri, 11 Oct 2024 08:05:18 EST

Urine proteome of male rats on mating day and next day compared. 54 differential proteins identified, most related to spermatogenesis, showing potential of urine proteome for study.

Research Points to Potential New Treatment for Aggressive Prostate Cancer Subtype

Michigan Medicine - University of Michigan — Fri, 04 Oct 2024 11:00:00 EST

In two new papers, both published in Cell Reports Medicine, researchers from the University of Michigan Rogel Cancer Center describe the mechanisms of how alterations in the CDK12 gene drive prostate cancer development and report on a promising degrader that targets CDK12 and a related gene to destroy tumors.

What Sperm Health Could Reveal About Your and Your Family's Health

University of Utah Health — Tue, 01 Oct 2024 15:05:43 EST

Pregnant people are bombarded with advice about how to keep their future children healthy. While parents worry about nutritional supplements and exercise, one aspect is less often discussed: how paternal reproductive health can be an indicator for the health of their children and, perhaps surprisingly, the rest of the family.

Director of Counseling Services Researches Why Male College Students Are Reluctant to Seek Counseling

University of Arkansas at Little Rock — Mon, 30 Sep 2024 10:05:21 EST

As head of Counseling Services at UA Little Rock, Dr. Aresh Assadi has counseled many college students during his 13 years at the university, but there is one question that has often plagued him early on in his career. Why do so few male college students seek counseling when compared to women?

IMRT and Proton Therapy Offer Equally High Quality of Life and Tumor Control for People with Prostate Cancer

American Society for Radiation Oncology (ASTRO) — Mon, 30 Sep 2024 10:00:00 EST

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy -- proton beam therapy or intensity modulated radiation therapy (IMRT) -- achieved equally high rates of tumor control with no differences in patient-reported quality of life, according to a first-of-its-kind phase III clinical trial comparing the two technologies. Findings of the PARTIQoL trial will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.